1-7 of 7
Melinda Burgess
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biological Features of Response to Immune Checkpoint Inhibitor and Rituximab Priming in Diffuse Large B-Cell Lymphoma

Rakin Chowdhury, Kate Manos, Melinda Burgess, Geoffrey Chong, Sze-Ting Lee, Zachary Hawula, Nella Tuczko, Charmaine Smith, Tineke Fancourt, Leonid Churilov, Andrew Scott, Allison Barraclough, Joel Wight, Joe McKendrick, Wendi Lin, Fiona Swain, Eliza A. Hawkes, Colm Keane
Journal: Blood
Blood (2024) 144 (Supplement 1): 6213.
https://doi.org/10.1182/blood-2024-201230
Published: 2024
Journal Articles

Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse

Fiona Swain, Melinda Burgess, Sarah Kempe, Muhammed B. Sabdia, Andrea S Henden, Joel Wight, Eliza A. Hawkes, Howard Mutsando, Dipti Talaulikar, Lilia Merida de Long, Simone Birch, Penelope Wyche, Zachary Hawula, Rakin Chowdhury, Maher K. Gandhi, Colm Keane
Journal: Blood
Blood (2024) 144 (Supplement 1): 3006.
https://doi.org/10.1182/blood-2024-199352
Published: 2024
Journal Articles

High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL

Muhammed B. Sabdia, Melinda Burgess, Soi Cheng Law, Lauren A Thurgood, Stephen Kazakoff, Fiona Swain, Joshua W.D. Tobin, Peter Mollee, Ann-Marie Patch, Maher K Gandhi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3260.
https://doi.org/10.1182/blood-2023-174149
Published: 2023
Journal Articles

Emergence of Fc-Gamma-Riib-Dominance Contributes to Resistance to Therapeutic Antibodies in Patients with Chronic Lymphocytic Leukaemia

Melinda Burgess, Sally Mapp, MBBS, PhD FRACP, FRCPA, Roberta Mazzieri, PhD, Jonathan Ellis, BSc, MSc, PhD, Catherine Cheung, Lynne Chambers, Stephen Mattarollo, BSc, PhD, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA, Devinder Gill, MB FRCPath FRACP FRCPA, Nicholas Saunders, BSc, PhD
Journal: Blood
Blood (2015) 126 (23): 447.
https://doi.org/10.1182/blood.V126.23.447.447
Published: 2015
Journal Articles

Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL)

Peter Mollee, Melinda Burgess, Nigel McMillan, Nicholas Saunders, Catherine Cheung, Michael Hallek, M.D. Ph.D., Devinder S Gill
Journal: Blood
Blood (2013) 122 (21): 2866.
https://doi.org/10.1182/blood.V122.21.2866.2866
Published: 2013
Journal Articles

CD62L Expression Is Associated With Chronic Lymphocytic Leukemia (CLL) Cell Survival In Vitro and Represents a Novel Therapeutic Target In CLL

Melinda Burgess, Peter Mollee, Richa Singhania, Catherine Cheung, Lynne Chambers, Reynolds Brent, Louise Smith, Nicholas Saunders, Nigel McMillan, Devinder S Gill
Journal: Blood
Blood (2013) 122 (21): 4136.
https://doi.org/10.1182/blood.V122.21.4136.4136
Published: 2013
Journal Articles

Identification of Two Novel Chemokines (CCL2 and CXCL2) in B-Chronic Lymphocytic Leukaemia (B-CLL) and Prolonged Survival of Primary B-CLL Cells in Vitro

Devinder Gill, MB, FRCPath, FRACP, FRCPA, Melinda Burgess, Louise Knop, BSc, Peter Mollee, MBBS, FRCPA, FRACP, MMSc, Nigel McMillan, PhD
Journal: Blood
Blood (2008) 112 (11): 3157.
https://doi.org/10.1182/blood.V112.11.3157.3157
Published: 2008